Clinical Characteristics, Including History of MI and Stroke, Among US Post-menopausal Women Initiating Treatment With Romosozumab and Other Anti-osteoporosis Therapies (20190205)First published 14/09/2020 Last updated 12/05/2025 EU PAS number: EUPAS37160StudyFinalised